Onconova Implementation Guide
0.2.0 - ci-build

Onconova Implementation Guide - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

ValueSet: Tumor Board Recommendations Value Set

Official URL: http://onconova.github.io/fhir/ValueSet/onconova-vs-tumor-board-recommendations Version: 0.2.0
Active as of 2026-03-18 Computable Name: OnconovaTumorBoardRecommendations

Recommendations that may be made by a tumor board for a cancer patient.

References

Logical Definition (CLD)

This value set includes codes based on the following rules:

 

Expansion

Expansion from tx.fhir.org based on:

  • Loinc v2.81
  • SNOMED CT International edition 01-Feb 2025

This value set contains 21 concepts

SystemCodeDisplay (en)JSONXML
http://snomed.info/sct  420227002:363702006=(386053000:363702006=387713003)420227002|Advice to|:363702006|Has focus|=386053000|Investigations|:363702006|Has focus|=387713003|Surgical procedure (procedure)|
http://snomed.info/sct  420227002:363702006=(386053000:363702006=1287742003)420227002|Advice to|:363702006|Has focus|=386053000|Investigations|:363702006|Has focus|=1287742003|Radiotherapy|
http://snomed.info/sct  420227002:363702006=(386053000:363702006=(276239002:363704007=255470001))420227002|Advice to|:363702006|Has focus|=386053000|Investigations|:363702006|Has focus|=276239002|Therapy|:363704007|Procedure site|=255470001|Local|
http://snomed.info/sct  420227002:363702006=(277132007:363702006=(64572001:278201002=74964007))420227002|Advice to|:363702006|Has focus|=277132007|Therapeutic procedure|:363702006|Has focus|=64572001|Disease|:278201002|Classification|=74964007|Other|
http://snomed.info/sct  306806004:246486007=372688009306806004|Advice to continue with drug treatment|:246486007|Agent used|=372688009|Antineoplastic agent (substance)|
http://snomed.info/sct  420227002:363702006=(390906007:363702006=255238004)420227002|Advice to|:363702006|Has focus|=390906007|Follow-up encounter (procedure)|:363702006|Has focus|=255238004|Continuous|
http://snomed.info/sct  420227002:363702006=(386053000:363702006=709491003)420227002|Advice to|:363702006|Has focus|=386053000|Investigations|:363702006|Has focus|=709491003|Enrollment in clinical trial (procedure)|
http://snomed.info/sct  420227002:363702006=396927009420227002|Advice to|:363702006|Has focus|=396927009|Molecular testing, diagnostic (procedure)|
http://snomed.info/sct  420227002:363702006=117614009420227002|Advice to|:363702006|Has focus|=117614009|Laboratory procedure, review by pathologist|
http://snomed.info/sct  306807008:363701004=372688009306807008|Advice to start taking medication|:363701004|Direct substance|=372688009|Antineoplastic agent (substance)|
http://snomed.info/sct  306806004:363701004=372688009306806004|Advice to continue with drug treatment|:363701004|Direct substance|=372688009|Antineoplastic agent (substance)|
http://snomed.info/sct  304540007:363701004=372688009304540007|Advice to stop taking medication|:363701004|Direct substance|=372688009|Antineoplastic agent (substance)|
http://snomed.info/sct  420227002:363702006=1345242003420227002|Advice to|:363702006|Has focus|=1345242003|Maintenance antineoplastic therapy (regime/therapy)|
http://snomed.info/sct  420227002:363702006=(386053000:363702006=77465005)420227002|Advice to|:363702006|Has focus|=386053000|Investigations|:363702006|Has focus|=77465005|Transplantation|
http://snomed.info/sct  420227002:363702006=306237005420227002|Advice to|:363702006|Has focus|=306237005|Referral for palliative care|
http://snomed.info/sct  420227002:363702006=306109009420227002|Advice to|:363702006|Has focus|=306109009|Referral to pain management service|
http://snomed.info/sct  420227002:363702006=(306226009:363702006=363346000)420227002|Advice to|:363702006|Has focus|=306226009|Referral to mental health counselling service|:363702006|Has focus|=363346000|Malignant tumour|
http://snomed.info/sct  420227002:363702006=363702006420227002|Advice to|:363702006|Has focus|=363702006|Has focus|
http://loinc.org  LA14020-4Genetic counseling recommended
http://loinc.org  LA14021-2Confirmatory testing recommended
http://loinc.org  LA14022-0Additional testing recommended

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code